These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 28785557)

  • 1. The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies.
    Singh VK; Saini A; Chandra R
    Front Mol Biosci; 2017; 4():52. PubMed ID: 28785557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine-mediated cancer stem cell therapy.
    Shen S; Xia JX; Wang J
    Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system.
    Xie FY; Xu WH; Yin C; Zhang GQ; Zhong YQ; Gao J
    World J Gastrointest Oncol; 2016 Oct; 8(10):735-744. PubMed ID: 27795813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can nanomedicines kill cancer stem cells?
    Zhao Y; Alakhova DY; Kabanov AV
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1763-83. PubMed ID: 24120657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradicating the tumor "seeds": nanomedicines-based therapies against cancer stem cells.
    Li L; Ni R; Zheng D; Chen L
    Daru; 2023 Jun; 31(1):83-94. PubMed ID: 36971921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impediments of Cancer Stem Cells and An Exploration into the Nanomedical Solutions for Glioblastoma.
    Jain H; Dhawan P; Rao S; Lalwani N; Shand H
    Anticancer Agents Med Chem; 2023; 23(4):368-382. PubMed ID: 36056850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.
    Malhi S; Gu X
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1177-201. PubMed ID: 25601619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cell theory: therapeutic implications for nanomedicine.
    Wang K; Wu X; Wang J; Huang J
    Int J Nanomedicine; 2013; 8():899-908. PubMed ID: 23467584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Design of Nanotherapeutics Based on the Five Features Principle for Potent Elimination of Cancer Stem Cells.
    Zhang Z; Deng Q; Xiao C; Li Z; Yang X
    Acc Chem Res; 2022 Feb; 55(4):526-536. PubMed ID: 35077133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence.
    Aramini B; Masciale V; Grisendi G; Bertolini F; Maur M; Guaitoli G; Chrystel I; Morandi U; Stella F; Dominici M; Haider KH
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Cancer Stem Cell Markers or Pathways: A Potential Therapeutic Strategy for Oral Cancer Treatment.
    Lee JW; Lee HY
    Int J Stem Cells; 2021 Nov; 14(4):386-399. PubMed ID: 34711702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors.
    Hong IS; Lee HY; Nam JS
    Recent Pat Anticancer Drug Discov; 2015; 10(1):2-22. PubMed ID: 25479037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells and drug resistance: the potential of nanomedicine.
    Vinogradov S; Wei X
    Nanomedicine (Lond); 2012 Apr; 7(4):597-615. PubMed ID: 22471722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges.
    Yun EJ; Lo UG; Hsieh JT
    Asian J Urol; 2016 Oct; 3(4):203-210. PubMed ID: 29264188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular targets, therapeutic agents and multitasking nanoparticles to deal with cancer stem cells: A narrative review.
    Doustmihan A; Fathi M; Mazloomi M; Salemi A; Hamblin MR; Jahanban-Esfahlan R
    J Control Release; 2023 Nov; 363():57-83. PubMed ID: 37739017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding and targeting cancer stem cells: therapeutic implications and challenges.
    Chen K; Huang YH; Chen JL
    Acta Pharmacol Sin; 2013 Jun; 34(6):732-40. PubMed ID: 23685952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting cancer stem cells in drug discovery: Current state and future perspectives.
    Du FY; Zhou QF; Sun WJ; Chen GL
    World J Stem Cells; 2019 Jul; 11(7):398-420. PubMed ID: 31396368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.